Researchers have identified 453 unique malaria-derived peptides presented by human leukocyte antigen class I on infected reticulocytes, offering potential targets for a broad-spectrum vaccine.
Researchers have identified 453 unique malaria-derived peptides presented by human leukocyte antigen class I on infected reticulocytes, offering potential targets for a broad-spectrum vaccine.